Pubblicazioni

Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia

2021 - JOURNAL OF HEMATOLOGY & ONCOLOGY

Pimpinelli, F; Marchesi, F; Piaggio, G; Giannarelli, D; Papa, E; Falcucci, P; Spadea, A; Pontone, M; Di Martino, S; Laquintana, V; La Malfa, A; Di Domenico, Enea Gino; Mengarelli, A

Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution

2021 - JOURNAL OF HEMATOLOGY & ONCOLOGY

Pimpinelli, F; Marchesi, F; Piaggio, G; Giannarelli, D; Papa, E; Falcucci, P; Pontone, M; Di Martino, S; Laquintana, V; La Malfa, A; DI DOMENICO, Enea Gino; Mengarelli, A